soul trial oral semaglutide cardiovascular outcomes soul trial results Reduces CV Events in T2DM β (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine π§ͺ T2DM + ASCVD/CKD π Oral semaglutide 14 mg vs placebo π Oral semaglutide found to lower
Description
Many said they had turned to online prescriptions to access the drugs
Diabetes 71 , 11151127 (2022)
These inconsistencies can frustrate both providers and patients, underscoring the need for expertise in navigating the varying expectations of insurers
Session 2: Personalized Fuel Plan Using everything weve learned, well design a nutrition plan that actually works for your life
Struan Coleman, board certified orthopedic surgeon and microbiologist
Clinical trials found semaglutide reduces the risk of a heart attack, stroke or cardiovascular death
